HOME
ABOUT US
TECHNOLOGY
PIPELINES
NEWS
JOIN US
CONTACT
News
CriCode Annouces FDA Granted Fast Track Designation to HM2002
From Refractory Angina Pectoris to Chronic Coronary Syndrome, CirCode's Circular RNA Therapeutic HM2002 has received clinical approval once again!
CirCode's Circular RNA Therapeutic HM2003 Receives FDA Orphan Drug Designation for Thromboangiitis Obliterans
CirCode Biomed Announces FDA Clearance for IND Application of HM2002, the world's first circular RNA drug being administrated in patients
CirCode Biomed Just Received First Ever Circular RNA IND Approval from NMPA